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Background: The worldwide increase in life expectancy has been associated with an increase in age-related
morbidities. The underlying mechanisms resulting in immunosenescence are only incompletely understood.
Chronic viral infections, in particular infection with human cytomegalovirus (HCMV), have been suggested as a
main driver in immunosenescence. Here, we propose that rhesus macaques could serve as a relevant model to
define the impact of chronic viral infections on host immunity in the aging host. We evaluated whether chronic
rhesus CMV (RhCMV) infection, similar to HCMV infection in humans, would modulate normal immunological
changes in the aging individual by taking advantage of the unique resource of rhesus macaques that were bred
and raised to be Specific Pathogen Free (SPF-2) for distinct viruses.
Results: Our results demonstrate that normal age-related immunological changes in frequencies, activation,
maturation, and function of peripheral blood cell lymphocytes in humans occur in a similar manner over the
lifespan of rhesus macaques. The comparative analysis of age-matched SPF-2 and non-SPF macaques that were
housed under identical conditions revealed distinct differences in certain immune parameters suggesting that
chronic pathogen exposure modulated host immune responses. All non-SPF macaques were infected with
RhCMV, suggesting that chronic RhCMV infection was a major contributor to altered immune function in non-SPF
macaques, although a causative relationship was not established and outside the scope of these studies. Further,
we showed that immunological differences between SPF-2 and non-SPF macaques were already apparent in
adolescent macaques, potentially predisposing RhCMV-infected animals to age-related pathologies.
Conclusions: Our data validate rhesus macaques as a relevant animal model to study how chronic viral
infections modulate host immunity and impact immunosenescence. Comparative studies in SPF-2 and non-SPF
macaques could identify important mechanisms associated with inflammaging and thereby lead to new therapies
promoting healthy aging in humans.
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Immune development and aging are dynamic processes
that are governed by many distinct, yet interacting
factors. Worldwide, as lifespans are generally increas-
ing, there is a concomitant increase in age-related mor-
bidities, particularly cardiovascular diseases, increased
susceptibility to seasonal infections, cancers, and neu-
rodegenerative disorders. A unifying link between the
higher rates of these disparate diseases observed in
aging populations is the progressive decline in immune
functions. This phenomenon has been termed immu-
nosenescence. The etiologies of immunosenescence are
incompletely defined. A central driving force in the de-
cline of immune function is the inherent process of
progressive thymic involution, which results in an ex-
tremely restricted generation of naïve T cells by the
fifth or sixth decades of life. However, studies over the
past several years have emphasized the critical import-
ance of extrinsic factors, which when layered over
thymic involution, can further enhance immune dys-
function and thereby increase the rates of morbidity
and mortality in aging individuals.
Several hypotheses have been presented to explain the
mechanistic basis for increased disease susceptibility asso-
ciated with aging. A main focus has been on the age-
related development of a proinflammatory state, termed
inflammaging. Although multiple studies have demon-
strated increased production of inflammatory cytokines
with age [1,2], the causes for inflammaging are likely
multifactorial and remain to be determined. For example,
polymorphisms in genes for IL-6, IL-10, and TLR4 have
been associated with increased inflammation during aging
[3-10]. This association was more pronounced in men
than in women suggesting that hormones may influence
the aging process. Indeed, age-related alterations of the
endocrine system have been implied in altered immune
responses of aging individuals (reviewed in [7]).
An alternative theory points to chronic infections as
major driver in immunosenescence [11], and, in fact, the
process of immunosenescence and inflammaging may be
inextricably intertwined. Among the various known
chronic viral pathogens, human cytomegalovirus (HCMV)
in particular has been suggested to be associated with re-
duced immune function in older individuals [12-15].
HCMV is ubiquitous throughout the world with adult
seroprevalence rates of 50-100%. HCMV, a member of the
Herpesvirales order of viruses, is considered to be a virus
with low pathogenic potential in immunocompetent hosts,
but like all Herpesvirales members, it establishes lifelong
persistence within the infected individual. Persistence is
characterized by the presence of cells harboring latent
HCMV genomes that periodically and asymptomatically
reactivate to produce progeny virions that can be secreted
in bodily fluids. The repeated and persistent antigenicstimulation of the immune host by HCMV, despite its low
pathogenic potential, results in a unique virus-host rela-
tionship unlike that of any other virus, and this relation-
ship has important clinical implications in relation to
immunosenescence. A seminal study by Sylwester et al.
quantified the CD4+ and CD8+ T cell responses to the
HCMV proteome in 32 healthy long-term HCMV-
infected individuals [16]. On average, almost 10% of
memory CD4+ and CD8+ T cells are specific to HCMV
antigens, far exceeding in magnitude the frequency of
antigen-specific T cells to any other pathogen [17-20].
Other studies have indicated that there are progressive oli-
goclonal expansions of some of the HCMV-specific T cell
populations. The majority of HCMV-specific effector
memory cells are terminally differentiated and show re-
duced function, and are therefore considered immunose-
nescent [13]. At the same time, the persistence of antigens
will continuously induce stress signals promoting inflam-
mation [13]. Although seminal studies like the OCTA,
NONA, and NHANES [21-24] cohort studies have clearly
shown a statistical association between aging, reduced im-
mune function, limited responsiveness to vaccines, in-
creased C-reactive protein (CRP) levels, and HCMV
seroprevalence, cause and effect cannot be conclusively
distinguished [11,13,21,25-28]. An alternative hypothesis
proposes that the vast expansion of HCMV-specific T cells
consumes the available finite “niche” for immune cells and
interferes with the de novo development of effector and
memory cells targeting other pathogens or vaccines.
The underlying mechanisms of and associations be-
tween chronic infections and immune function could be
best determined and tested in an animal model that
closely recapitulates characteristics of human develop-
ment, physiology, immunology, virology, and longevity.
We propose that rhesus macaques represent such a
model. Wild and captive populations of rhesus macaques
are ubiquitously infected with rhesus cytomegalovirus
(RhCMV), as well as other persistent pathogens [29].
Furthermore, RhCMV-infected monkeys show similar
age-associated immune changes as those observed in
HCMV-infected humans, including decreased CD4+ to
CD8+ T cell ratios and the accumulation of terminally
differentiated CD8+CD28− T cells [30-32]. In captivity,
these animals live for an average of 25 years and a max-
imum of approximately 40 years, whereas macaques in
the wild generally live 12–18 years [30,33,34]. Macaques
undergo similar age-related developmental, hormonal
and immunological changes, but in an accelerated fash-
ion compared to humans due to their shorter lifespan.
The current study aimed to demonstrate that the rhe-
sus macaque model of HCMV persistence could be uti-
lized as a relevant nonhuman model to study chronic
infection-induced alterations of immune responsiveness
as it applies to aging humans. Taking advantage of the
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raised to be Specific Pathogen Free (SPF-2 macaques)
for specific viruses (described below), we compared gen-
eral age-associated changes in peripheral blood popula-
tions and in T cell function between SPF-2 and non-SPF
macaques from birth until adulthood. We further inves-
tigated how immune responses to RhCMV evolve over
the lifetime of a chronically infected animal in relation
to virological parameters, and whether immune cell pop-
ulations of RhCMV-infected animals would display dis-
tinct functional characteristics compared to age-matched
SPF animals without RhCMV infection. Our results
show that some age-related changes in major blood cell
populations from birth to adulthood are common to
both SPF-2 and non-SPF macaques. In addition though,
our study clearly demonstrates that chronic RhCMV
infection modulates immune development over the life-
time of the host. These altered responses were already evi-
dent in adolescent RhCMV-infected macaques, thereby
potentially predisposing these non-SPF animals for inflam-
maging in late adulthood. These data support the idea that
rhesus macaques could serve as a model system to study
inflammaging, and provide a foundation for future studies
to delineate specific mechanisms of RhCMV-induced
immunosenescence with the long-term goal of developing
therapeutic interventions, targeted to young adults, to pre-
vent the onset of inflammaging.Results
Immunological changes in peripheral blood cell
population of SPF-2 macaques from birth to adulthood
An important first step towards our long-term goal of
using the rhesus macaque model of RhCMV infection as a
model system of health over the lifespan was to assess the
influence of two comorbidities of immune function in
humans: (i) maturation and aging of the immune system,
and (ii) chronic exposure to persistent viral pathogens.
Our approach was to characterize age-associated changes
in basic immune cell populations and their functions in
the presence or absence of infection with simian herpesvi-
ruses in general, and RhCMV in particular. There is ample
evidence from human natural history studies that mi-
crobes that establish lifelong persistent infections in im-
mune hosts, most notably HCMV, can profoundly alter
leukocyte responses, which could potentially confound in-
terpretation of changes in leucocyte populations associ-
ated with aging in rhesus macaques. Accordingly, we
assessed age-related changes in major peripheral blood
populations from birth to adulthood in SPF-2 macaques.
We then tested whether non-SPF macaques underwent
similar changes in immune populations with age, and
whether altered immune parameters could be correlated
to RhCMV infection status.Both acute and long-term changes were observed in
the dynamics of leukocyte subsets during the rhesus
macaque lifespan. During infancy (0–1 year), the num-
bers of neutrophils and monocytes appeared to decline.
Indeed, 1-year old macaques had significantly lower
neutrophil numbers than newborn macaques at birth
(p < 0.0007, Figure 1A, Additional file 1: Table S1). The
first 16 to 20 weeks of life represented the period of the
greatest changes in cell numbers. During this period,
mean neutrophil counts declined by 45%. During the
same time period, monocyte counts declined by 49%,
but in contrast to neutrophils, monocyte numbers
rebounded and there was not a demonstrable difference
between absolute monocyte counts at birth or 48 weeks
(p = 0.1099; Figure 1B). Contemporaneous to these
changes in neutrophil and monocyte counts, lympho-
cyte numbers increased (Figure 1C, Additional file 1:
Table S1). The increase in lymphocytes was the result
of both increasing B and T cell numbers (Figures 1D
and E). Among the T lymphocytes, CD4+T cells repre-
sented the vast majority of T cells at birth, and, despite
minor fluctuations, absolute CD4+T cell numbers did not
significantly change throughout the first year (p = 0.2697;
Figure 1F; Additional file 1: Table S1). However, because
the CD8+T cell population expanded after birth (increase of
mean CD8+T cells/μl blood from 441 at birth to 1150 at
week 20; p < 0.0001) (Figure 1F, Additional file 1: Table S1),
the percentage of CD4+T cells decreased concurrent with
the rise in the CD8+T cell percentage (Additional file 1:
Table S1). Therefore, the CD4:CD8 T cell ratio decreased
from 4.8 at birth to 2.7 at week 12, stabilizing around 2.3 at
week 20 and week 40 (Figure 1G). Thus, during the first
few months of life, the various blood cell populations
underwent obvious changes in their relative frequencies
with cell numbers remaining more stable after 20 weeks of
age (Figure 1). It is important to note that maintaining the
animals in SPF-2 housing conditions absolutely restricted
their potential exposure to multiple viruses normally
endemic in the non-SPF animals. Previous seroepidemiolo-
gical and molecular studies have demonstrated that infants
born to non-SPF dams during the first year of life are
increasingly likely to become infected with RhCMV, SFV,
and RRV due to repeated exposure of bodily fluids
containing infectious virus particles. Accordingly,
changes in lymphoid subset profiles largely reflected
age-related changes not influenced by these persistent
viral pathogens (discussed in further detail below). In
fact, nursery-reared infants born to non-SPF dams, and
therefore experiencing minimal pathogen exposure, im-
munologically maturated identical to the SPF-infants (data
not shown). The developmental changes occurred in both
male and female infant macaques, and in both Indian and
Chinese SPF-2 infants (data not shown), suggesting that
macaque gender or genetic differences did not overtly
Figure 1 Longitudinal changes in major blood population during the first year of life. The graphs show longitudinal changes in the absolute
frequencies of neutrophils (A), monocytes (B), or lymphocytes (C) in peripheral blood of SPF-2 infant macaques from birth to 1 year. Panels (D) to
(F) illustrate the changes of B cells, T cells, and the CD4+ and CD8+T cell populations, respectively, in the first year of life. Data are represented as mean
absolute numbers of 23 SPF-2 infants ± SEM per microliter of blood. Panel (G) shows the significant decline in the CD4:CD8 T cell ratio from birth to 3
months of age, after which the ratio remained stable throughout week 40. Boxplot horizontal bars indicate the median value in each age group.
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Age-related changes from infancy to adulthood in the
same leucocyte populations were examined by cross-
sectional analysis of SPF-2 rhesus macaques from different
age groups (Table 1). Both neutrophils and monocytes
were significantly higher (p < 0.0001 and p = 0.0354, re-
spectively; see Table 1) in adolescent (3 to 5 years) com-
pared to 1-year old infant macaques, whereas B and T
lymphocytes (both CD4+ and CD8+ T cell subsets) were
significantly lower (p < 0.0001). The CD4:CD8 ratio
remained stable despite changes in CD4+ and CD8+ T cell
numbers. The comparison of young adults (6 to 10 years)
to adolescents (3 to 5 years) revealed higher monocyte
numbers (p < 0.0001), but lower B (p = 0.0252) and T cell
numbers (p = 0.0031). The reduction in CD3+T cells was
due almost exclusively to a decline in CD4+T cells, result-
ing in an inversion of the CD4:CD8 ratio. The relative de-
cline in CD4+ T cells in young adults compared toadolescents (Table 1) may have been a factor of sampling
only few young adult SPF-2 animals available for this
study. Nevertheless, the data demonstrate that there are
continued significant changes in the frequencies of periph-
eral blood cell populations as animals age, changes that
are also characteristic of many aging humans.
Effect of pathogen exposure on age-related changes in
immune cell populations
Having defined the phenotypic changes in peripheral
blood T and B cell populations from infancy to young
adulthood of SPF-2 animals, similar analyses were per-
formed in adolescent and aged non-SPF macaques. Gener-
ally, analogous changes in peripheral blood lymphocyte
populations were observed between non-SPF adolescent
and adult macaques to those that were observed in SPF-2
animals (Table 2). With the exception of monocytes, there
were significant decreases in almost all leucocyte popula-
tions, including neutrophils, B cells, total CD3+T cells, and
Table 1 Peripheral blood mononuclear cell populations in SPF-2 rhesus macaques
Cell population Median cell numbers/ μl blood (Minimum-Maximum)
Infantsa Adolescents Infants vs.
Adolescentsb
Young Adults Adolescents
vs. Young
Adultsb
(n = 22) (n = 30) (n = 8)
Neutrophils 1952 10502 p < 0.0001 11274 NSc
(990–4900) (6667–18502) (10032–19694)
Monocytes 182 328 p = 0.0354 938 p < 0.0001
(45–637) (202–855) (476–2030)
Lymphocytes 4547 1949 p < 0.0001 710 p = 0.0014
(2277–7314) (1107–3088) (342–2388)
B Cellsd 1464 474 p < 0.0001 224 p = 0.0252
(649–2716) (136–808) (97–736)
T Cellse 2759 1257 p < 0.0001 486 p = 0.0031
(1373–4811) (336–1899) (194–1760)
CD4+ T 1863 828 p < 0.0001 124 p < 0.0001
(850–3598) (459–1319) (15–734)
CD8+ T 820 397 p < 0.0001 363 NS
(357–1843) (209–1109) (179–1026)
CD4:CD8 Ratio 2.3 2.0 NS 0.4 p < 0.0001
(1.2-3.6) (0.7-3.8) (0.1-0.8)
aage: 40 weeks; bGroup comparison was performed by Mann–Whitney test; cNS = not significant; dB cells are defined as CD20+ lymphocytes; eT cells are defined
as CD3+ lymphocytes.
Table 2 Peripheral blood populations in non-SPF macaques
Cell population Median cell numbers/ μl blood (Minimum-Maximum)
Adolescents Adults Adolescents vs.
Adultsa(n = 50) (n = 100)
Neutrophils 9576 8280 0.0119
(1936–21156) (2520–20169)
Monocytes 392 326 NSb
(70–1620) (42–1494)
Lymphocytes 3037 1248 p < 0.0001
(756–8073) (262–3888)
B Cells 1445 366 p < 0.0001
(269–4317) (69–1341)
T Cells 1155 745 p < 0.0001
(311–3730) (103–2798)
CD4+ T 753 433 p < 0.0001
(195–2202) (44–1606)
CD8+ T 310 250 p = 0.0139
(99–1401) (43–1276)
CD4:CD8 Ratio 2.4 1.8 p < 0.0001
(1.4-4.0) (0.2-4.2)
aData were compared by Mann–Whitney test. bNS = non-significant.
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However, SPF-2 adolescent macaques had significantly
(p < 0.0001) lower lymphocyte numbers than the non-
SPF adolescent macaques (median: 1949/μl blood vs.
3037/μl blood, respectively; Table 3). Lower lympho-
cyte numbers were likely the result of lower median
B cell numbers in the SPF-2 (474 /μl blood) compared to
non-SPF (1445 /μl) adolescent macaques (p < 0.0001), be-
cause total median T cell numbers did not differ signifi-
cantly between the groups (1257 vs. 1155 in SPF-2 and
non-SPF adolescents, respectively; Table 3). Despite com-
parable T cell numbers, distinct from the SPF-2 macaques,
significant reductions in both the CD4+T (p < 0.0001) and
the CD8+T cell compartment (p = 0.0139) were observed
in the non-SPF animals. This also resulted in a significant
reduction of the CD4:CD8 T cell ratio (p < 0.0001), al-
though the inversion noted in SPF-2 animals was not ob-
served in non-SPF macaques (Tables 2 and 3). As defined
below (Materials and Methods), the infectious distinction
between SPF-2 and non-SPF populations was that SPF-2
animals were uninfected with RhCMV, herpes B virus,
RRV, and SFV. Since both SPF-2 and non-SPF adolescent
and adult study animals were housed outdoors under
identical housing conditions, it is highly probable that
both cohorts were exposed to the identical spectrum of
microbes endemic in the environment of the CNPRC.Table 3 Peripheral blood populations in adolescent SPF-2
and non-SPF macaques
Cell
population
Median cell numbers/ μl blood
(Minimum-Maximum)
SPF-2
Adolescents
Non-SPF
Adolescents
SPF-2 vs.
Non-SPFa
(n = 30) (n = 50)
Neutrophils 10502 9576 NSb
(6667–18502) (1936–21156)
Monocytes 328 392 NS
(202–855) (70–1620)
Lymphocytes 1949 3037 p < 0.0001
(1107–3088) (756–8073)
B Cells 474 1445 p < 0.0001
(136–808) (269–4317)
T Cells 1257 1155 NS
(336–1899) (311–3730)
CD4+ T 828 753 NS
(459–1319) (195–2202)
CD8+ T 397 310 p = 0.0247
(209–1109) (99–1401)
CD4:CD8 Ratio 2.0 2.4 p = 0.0132
(0.7-3.8) (1.4-4.0)
aData were compared by Mann–Whitney test. bNS = non-significant.Infant outdoor-housed non-SPF animals were not in-
cluded in the comparative analysis because there is a dif-
ferential median age of seroconversion to RhCMV, SFV,
and RRV during the first year of life in outdoor-housed
animals [35].
T cell and B cell memory development in SPF-2 versus
non-SPF rhesus macaques
The age-related changes in lymphocyte population fre-
quencies were accompanied by immune maturation. As
expected, the majority of CD4+ and CD8+T cells of SPF-2
animals expressed a naïve phenotype at birth (Figure 2A).
Throughout the first year, naïve T cells (CD3+CD45RA
+CCR7+ or CD3+CD28+CD95−) declined, while the per-
centage of both central memory (TCM) and effector/effec-
tor memory (TE/EM)) T cells increased. The development
of memory CD8+T cells was more pronounced with close
to 15% of CD8+T cells expressing a TE/EM phenotype at
1 year compared to less than 1% of CD4+Tcells (Figure 2A;
Additional file 2: Table S2). Memory T cells further in-
creased in adolescent animals and in young SPF-2 adults,
as described for humans, memory T cells represented the
majority of CD4+ and CD8+T cells (Figure 2B).
Similar to SPF-2 macaques, non-SPF adult macaques
had fewer naïve and more memory CD4+ and CD8+T
cells compared to adolescent macaques (Figure 2B).
However, we noted some differences between SPF-2 and
non-SPF macaques within the memory T cell subset dis-
tribution. Specifically, adolescent non-SPF macaques had
higher frequencies of CD45RA−CD95+CD4+T cells and
CD45RA−CD28+CD8+T cells (Figure 2B). Adult non-SPF
macaques had significantly higher frequencies of
CD45RA+CD95+CD4+T cells compared to SPF-2 ma-
caques (mean percentages of 1.8% vs. 22%, respectively;
p < 0.0001). Increased memory CD4+T cell populations
in adolescent non-SPF compared to SPF-2 macaques
were consistent with higher frequencies of CD4+T cells
expressing CCR5, an activation marker that is absent on
naïve T cells (Table 4). In contrast, CD25+CD4+T cells
occurred at slightly higher percentages in SPF-2 adoles-
cents. The latter could represent higher numbers of
regulatory CD4+T cells in SPF-2 animals; however,
because CD25 is also upregulated on activated T cells,
and we did not assess functional parameters, this inter-
pretation remains speculative. Higher frequencies of
CD38+CD8+T cells in SPF-2 adolescents is likely related
with the reduced memory CD8+T cell development in
SPF-2 compared to non-SPF adolescent macaques (see
Figure 2B), because CD38 is expressed on almost all
infant T cells at birth and then declines slowly.
A temporal relationship was also observed between B
cell maturation and age. In the first year of life, there
was a continuous decline in naïve B cells (CD19+CD20
+CD27−IgD+) accompanied by a simultaneous increase
Figure 2 Memory T cell development. Panel A. Age-related changes in naïve and memory CD4+ and CD8+ T cell populations from birth to 1 year of
age, expressed as mean percentages ± SEM, of 23 SPF-2 infants are shown. The markers CD28 and CD95 were used to define naïve (CD28+CD95−; open
circles), central memory (CD28+CD95+; filled triangles), and effector/effector memory (CD28−CD95+; stars) T cell populations. Panel B. Naïve and
memory T cell populations in SPF-2 and non-SPF adolescent (white and grey striped bars, respectively) and adult (white dotted and grey-dotted bars,
respectively) macaques. The box-and-whisker plots show the 10–90 percentile range of the data of 30 SPF-2 adolescents, 8 SPF-2 young adults, 50
non-SPF adolescents and 100 adult non-SPF macaques. Significant differences between age groups were determined by one-way ANOVA and are
indicated as p values.
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B cells (both CD27+IgD− and double negative IgD−CD27
− B cells) (Figure 3A). As expected, frequencies of all
memory B cell populations were higher in adolescent and
adult macaques than in 1-year old infants independent of
SPF-2 status (data not shown). Interestingly, adolescent
non-SPF macaques had significantly higher frequencies of
switched CD27+IgD− (p = 0.0001) and double–negative
CD27−IgD− (p = 0. 0012) memory B cells, but fewer naïve
B cells and unswitched memory B cells than SPF-2adolescent macaques (p = 0.0002 and p = 0.003, respect-
ively; Figure 3B). Although similar trends were observed
for naive and switched memory B cell populations in
young adult SPF-2 and adult non-SPF macaques, these dif-
ferences did not reach statistical significance (p > 0.05);
likely the result of the low animal numbers (n = 8) and the
overall younger age of adult SPF-2 (6 to 10 years) com-
pared to non-SPF adult macaques (12 to 20 years).
Thus, in addition to comparable age-related changes
in B and T cell populations in SPF-2 and non-SPF
Table 4 T cell activation
Marker Mean cell numbers ± SEM / μl blood
SPF-2 Adolescents Non-SPF Adolescents Non-SPF Adults
SPF-2 vs.
Non-SPF
Adolescentsa
Non-SPF
Adolescents vs. Adultsa
CD4+T
CD25 15.89 ± 0.66 13.58 ± 0.45 p = 0.0015 13.88 ± 0.50 NS
CCR5 33.77 ± 2.12 62.92 ± 5.26 p < 0.0001 46.60 ± 3.86 p < 0.0010
CXCR3 NDb 310.80 ± 20.80 221.30 ± 12.40 p < 0.0001
HLA-DR 15.48 ± 1.29 13.27 ± 1.60 NSc 7.55 ± 0.54 p < 0.0001
HLA-DR+CD25+ 17.03 ± 5.49 5.00 ± 0.50 p = 0.0180 2.90 ± 0.27 p < 0.0001
CD8+T
CD38 388.50 ± 25.54 233.60 ± 25.72 p < 0.0001 107.30 ± 10.39 p < 0.0001
HLA-DR 14.94 ± 1.40 12.55 ± 1.42 NS 9.33 ± 0.76 p = 0.0385
CD38+HLA-DR+ 14.36 ± 1.34 9.12 ± 1.27 p < 0.0100 5.25 ± 0.66 p < 0.0010
aData between groups were compared by Mann–Whitney analysis. bND = not determined; c NS = not significant.
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maturation phenotypes, suggesting that both age and
pathogen exposure influenced T and B cell maturation.
Differences in T cell function between SPF-2 and non-SPF
macaques
To establish whether the phenotypic changes indicative
of immune maturation with age were associated with
altered T cell function, we measured non-specific T cell
responses in the different age groups of SPF-2 animals.
Consistent with the Th2-bias of infant CD4+T cell
response [36,37], prior to 4 weeks of age infants had low
frequencies of CD4+T cells producing IFΝ−γ, the
principle Th1 characterizing cytokine, in response to
polyclonal T cell stimulation (Figure 4, Additional file 3:
Table S3). The percentage of IFN-γ-producing CD4+T
cells increased from <0.015% in the first month to >0.1%
of total CD4+T cells by 40–48 weeks of age (Additional
file 3: Table S3; p = 0.002). In contrast, CD8+T cell IFN-γ
responses were consistently detected throughout the first
year and were of comparable magnitude ranging from
0.1 to 1% of all CD8+ T cells (Figure 4, Additional file 3:
Table S3, p = 0.111), implying that CD4+T cell-intrinsic
factors may interfere with IFN-γ production in neonates.
To measure more physiologically relevant responses,
we stimulated SPF-2 infant PBMC with anti-CD3 and
anti-CD28 antibodies to activate T cells directly through
the T cell receptor (TCR). Supernatants were collected
at 24 hours and analyzed for cytokines important in T
cell activation and CD4+T helper cell lineage differenti-
ation. This experiment included a group of 3 to 9 week
old SPF-2 infants (n = 8) and a second group of 10 to
16 week-old infant macaques (n = 8). As we did not de-
tect statistically significant differences in cytokineresponses between these two groups (data not shown),
we combined the data from both infant groups and
compared them to cytokine levels induced by TCR
stimulation in SPF-2 adolescent (n = 7) and SPF-2 young
adult macaques (n = 8). There was an age-dependent in-
crease in several cytokine responses to TCR stimulation
from infant to adult macaques (Figure 5A). In addition
to these quantitative changes, the quality of the response
differed between age groups. Consistent with the very
low IFN-γ response of infants, the ratio of IFN-γ:IL-4 was
lower in infant compared to adolescent and young adult
SPF-2 macaques (Figure 5B). Similarly, and despite in-
creasing production of both IL-10 and IFN-γ with age, the
IFN-γ:IL-10 ratio was also significantly lower in infants.
To validate our earlier conclusion that, in addition to
age, pathogen exposure influences T cell maturation and
function, we compared cytokine response to ConA stimu-
lation between SPF-2 and non-SPF adolescent macaques.
Most proinflammatory cytokines, including TNF-α, IL-6
(Figure 6A), IL-1β, and TNF-β (data not shown) were
expressed at higher levels in non-SPF than in SPF-2 ado-
lescent macaques. Although SPF-2 adolescents produced
significantly more IL-12p40 and had a higher IL-12:IL-10
ratio than non-SPF adolescents (Figure 6B), the lower
IFN-γ response of SPF-2 adolescents (Figure 5A) resulted
in a significantly lower ratio of IFN-γ: IL-4 compared to
non-SPF adolescent macaques (Figure 6B). Thus, the
overall cytokine response in non-SPF adolescents was in-
dicative of an immune-activating, inflammatory bias com-
pared to SPF-2 adolescent macaques, and this apparent
bias was maintained into adulthood. Although anti-
inflammatory cytokines (e.g. IL-10, IL-1Rα) and cytokines
associated with Th2 responses (IL-4, IL-9) were also pro-
duced at higher levels in adult compared to adolescent
Figure 3 B cell differentiation in SPF-2 macaques with age. Panel A: The normal developmental changes in peripheral blood B cell populations from
birth to 1 year of age in SPF-2 infant macaques (n = 16). Shown are mean values ± SEM for naïve, unswitched, isotype-switched and double-negative
memory B cell populations based on phenotypic characterization using CD27 and IgD. Panel B illustrates age-related changes in B cell populations
between infants at 40 weeks of age, adolescent (n = 8) and adult SPF-2 macaques (n = 8). The legend of the plots is as described in Figure 2. Significant
differences between age groups were determined by exact Mann–Whitney test and are indicated as p values.
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and the Th1-associated chemokine RANTES were in-
creased concurrently (Table 5).RhCMV immunity in adolescent and adult non-SPF
macaques
RhCMV is one of the most common pathogens present
in non-SPF rhesus macaque colonies. Thus, we wanted
to determine whether RhCMV infection status was asso-
ciated with any of our observed changes in immunedevelopment and maturation between SPF-2 and non-
SPF macaques.
We previously documented that about 90% of conven-
tional non-SPF macaques housed in outdoor corrals be-
come infected with RhCMV between 5–12 months of
age [38-40]. In agreement with these findings, in the
current study, RhCMV shedding was detected in the sal-
iva of most adolescent non-SPF macaques (Figure 7A).
RhCMV shedding was more frequent (78% vs. 28%), and
occurred at significantly higher titers (mean: 5.47 × 104
copies/ml with 95% CI of mean from 6665 to 102833) in
Figure 4 Age-dependent increase in infant IFN-γ CD4+T cell responses. The ability of CD4+ and CD8+T cells to produce IFN-γ in response to in vitro
PMA/ionomycin stimulation was assessed in 23 infant SPF-2 macaques at various time points from birth to 48 weeks of age using flow cytometric
analysis. The percentage of infant macaques with a positive IFN-γ response in CD4+ (left graph) or CD8+T cells (right graph) is shown for the time of
birth (week 0), and for weeks 4, 12, 24, and 48 of age. Bars at a specific time point show the percentage of animals with a positive CD4+ or CD8+T cell
response in less than 0.015% (white), between 0.015% and 0.1% (light grey), between 0.1% and 1.0% (dark grey), and in more than 1.0% (black) of the
CD4+ or CD8+T cell population. Additional file 3: Table S3 contains the extended data set used for the graphical representation here. Note the age-
dependent increase in the percentage of SPF-2 infants with higher frequencies of IFN-γ positive CD4+T cells. At birth, about 70% of infants have no or
only a weakly positive IFN-γ response in CD4+ T cells (<0.015%), whereas at 48 weeks of age 50% of the infants show responses >0.1% (p = 0.002;
Additional file 3: Table S3). In contrast, the magnitude of IFN-γ responses in CD8+T cells did not differ between newborn and 1 year old SPF-2 infant
macaques (Additional file 3: Table S3).
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2.31 × 103 copies/ml with 95% CI of mean from 348 to
4265) (Figure 7A). To confirm RhCMV infection in both
shedding and non-shedding macaques, we performed
serological testing. Adolescent and adult non-SPF ma-
caques showed similar RhCMV gB–specific neutralizing
antibody titers (Figure 7B), suggesting that once neutral-
izing antibody titers were induced, they persisted at
moderate to high levels. This result, similar to HCMV in
humans, is consistent with the lifelong persistence of
RhCMV in the animals without causing disease, despite
occasional virus shedding [38]. In the adolescent ma-
caques that shed RhCMV at higher titers and more
frequently, neutralizing antibody titers were weakly asso-
ciated with RhCMV shedding using Pearson correlation,
but not when a non-parametric Spearman’s rho test is
applied (Figure 7C). An association was not present in
adult macaques who shed RhCMV at low titers and in-
frequently (Figure 7D).
In contrast to neutralizing antibody responses,
RhCMV-specific T cell responses further increased with
age. Most of the adolescent non-SPF macaques pro-
duced only a limited number of cytokines and only at
low levels in response to in vitro RhCMV lysate stimula-
tion (Figure 8). Consistent with the expansion of mem-
ory T cells in adult compared to adolescent non-SPF
macaques, all adult RhCMV-infected macaques secreted
multiple cytokines and at higher levels than adolescent
RhCMV-infected macaques, although statistically signifi-
cant age-related differences were only observed for IL-6,
IL-1β, and IFN-γ (Figure 8). Median values of TNF-α
and RANTES were also higher in adult than in adoles-
cent macaques, but this difference did not reach statis-
tical significance (data not shown). Thus, reminiscent ofthe more inflammatory response to the non-specific
ConA stimulation in non-SPF compared to SPF-2 ma-
caques, antigen-specific responses to RhCMV lysate in
chronic RhCMV–infected macaques showed a proin-
flammatory cytokine bias.
Discussion
The goal of the study was to validate the rhesus ma-
caque model of RhCMV infection as a relevant animal
model to study immune modulation of aging and immu-
nosenescence by chronic viral infections. Towards this
goal, we confirmed that rhesus macaques undergo simi-
lar changes in frequencies, maturation, activation, and
function of peripheral blood cell populations from birth
to adulthood as humans. The comparison of immune
parameters in different age groups of SPF-2 and non-
SPF macaques revealed that chronic pathogen exposure
modulates host immunity.
In a first step to define normal developmental changes
in immune cell populations and their function with age,
we followed a cohort of SPF-2 infants from birth to
1 year of age. Our results show that the infant immune
system undergoes tremendous changes after birth, with
the most dramatic changes in cell frequencies occurring
in the first 3–4 months of life. Memory T and B cell
populations steadily increased throughout the first year,
and these phenotypic changes were associated with func-
tional changes. For example, the magnitude of IFN-γ
responses in CD4+T cells increased in the first year of
life. In contrast, the magnitude of CD8+T cell IFN-γ
responses was comparable at birth and 1 year of age,
and generally exceeded that of infant CD4+T cells, sug-
gesting that factors intrinsic to CD4+T cells regulate
IFN-γ production in CD4+ compared to CD8+ infant T
Figure 5 TCR-induced cytokine responses in PBMC of SPF-2 macaques of different age groups. Panel (A): The various graphs depict specific
cytokines produced by PBMC of infant (n = 16), adolescent (n = 7) and young adult SPF-2 macaques (n = 8) after 24 hours of stimulation with
anti-CD3 and anti-CD28 antibodies. Data are expressed in pg per milliliter (pg/mL) of culture supernatant. Panel (B) shows age-related changes in
the ratios of IFN-:IL-4 and IFN-γ:IL-10. Cytokine levels between the three distinct age groups were compared by one-way ANOVA and statistically
significant differences are indicated by p values. Each symbol represents an individual animal; horizontal lines indicate the median of the age-group.
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ported that the IFN-γ promoter is hypermethylated in
human infant CD4+T cells [41], and therefore futurestudies should determine whether epigenetic changes
during the first year of life could explain the observed
increase in IFN-γ production [42]. We acknowledge
Figure 6 Cytokine responses of adolescent SPF-2 and non-SPF macaques to ConA stimulation. Panel (A). The individual graphs show the production
of specific cytokines in PBMC of SPF-2 (open triangles; n = 20) or non-SPF adolescent macaques (filled triangles; n = 10) after in vitro stimulation with
Con A. Cytokines were measured in culture supernatants at 48 hours. Capped lines with p values indicate statistically significant differences between
the two groups determined by Mann–Whitney test. Each symbol represents an individual animal; horizontal lines indicate the median of the age group.
Panel (B) shows how the cytokine ratios of IL-12:IL-10 and IFN-γ:IL-4 differ between adolescent SPF-2 and non-SPF macaques.
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various factors. In infants specifically, rearing conditions
can dramatically affect immune development andfunction. A recent study demonstrated that dam-reared,
and therefore breast-fed infants, versus nursery-reared
infant rhesus macaques show dramatic differences in the
Table 5 Cytokine responses to in vitro ConA stimulation
Cytokine Median cytokine levels in pg/ ml (Minimum-Maximum)
SPF-2 Adolescents Non-SPF Adolescents SPF-2 vs. Non-SPF
Adolescentsa
Non-SPF Adults Non-SPF Adolescents
vs. Adultsa
Inflammatory
IL-6 58.0 647.7 p < 0.0500 1267.0 NSb
(8.6-1451) (207.6-1778) (268.2-2253)
TNF- 1198.0 3436.0 p < 0.0010 6181.0 p < 0.0500
(48.2-4103) (1260.0-6368.0) (2246–9517)
IL-1β 23.4 113.7 p < 0.0010 226.3 NS
(0.3-71.4) (25.5-259.0) (80.9-795.9)
TNF-β 334.7 1185.0 p < 0.0010 753.2 NS
(31.5-1089.0) (104.6-2307.0) (232.3-1465.0)
IL-12p40 1174.0 167.3 p < 0.0001 215.8 NS
(592.9-2068.0) (15.1-260.8) (96.2-606.6)
IL-15 4.0 11.3 p < 0.001 11.1 NS
(1.9-8.9) (0–16.2) (7.6-15.6)
CXCL-10 33.0 13.1 p < 0.0001 10.6 NS
(16.2-45.0) (3.0-23.4) (0.1-22.0)
Anti-Inflammatory
IL-10 53.5 171.2 p = 0.0251 489.7 p = 0.0115
(3.5-974.9) (20.0-453.0) (72.3-978.1)
IL-1Rα 6073.0 529.7 p < 0.0001 937.8 p = 0.0279
(1775–15352) (48.2-887.4) (266.6-3574.0)
Th differentiation
IL-2 2451.0 4892.0 NS 3511.0 NS
(19.4-21229.0) (40.6-7656.0) (814.1-23975)
IFN-γ 681.0 16058.0 p < 0.0010 19656 NS
(5.2-5832.0) (2704–20164) (14315–20941)
IL-4 1.3 3.9 p < 0.0500 9.3 p = 0.0015
(0.3-7.3) (1.1-8.6) (4.2-21.7)
IL-9 259.2 20.5 p < 0.0001 38.2 p = 0.0089
(126.2-512.0) (9.8-47.9) (24.2-103.3)
Chemokines
RANTES 11017.0 970.5 p < 0.0001 1818.0 p = 0.0089
(800.3-37070) (151.8-2041.0) (930.2-3434.0)
Eotaxin 13.3 21.3 p = 0.0301 21.7 NS
(4.1-24.1) (8.0-31.2) (1.5-25.5)
Cytokine Ratios
IL-12:IL-10 24.1 0.7 p < 0.0010 0.3 NS
(0.8-326) (0.2-1.1) (0.2-0.8)
IFN-γ:IL-4 508.2 4329.0 p < 0.0010 2032.0 p = 0.0350
(17.8-8997.0) (484.6-12917) (886.0-4871.0)
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Table 5 Cytokine responses to in vitro ConA stimulation (Continued)
IL-1β:IL-1Rα 0.004 0.36 p < 0.0001 0.27 NS
(0.0-0.0096) (0.04-3.69) (0.06-0.88)
RANTES:Eotaxin 611.3 41.0 p < 0.0001 79.8 p = 0.0435
(64.1-8074.0) (16.7-158.1) (52.9-1353.0)
aData were compared by Mann–Whitney test. bNS = non-significant.
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microbiota [43]. Thus, immune development and func-
tion in the early period of life from birth to 1 year might
be uniquely regulated by a multitude of intrinsic and ex-
trinsic factors. Nonetheless, our normative data on the
frequencies of peripheral blood cell populations, and on
T and B cell maturation in infant SPF-2 rhesus macaques
are remarkably similar and consistent with normal de-
velopmental changes observed in human infants [44,45].
Considering the potential impact of infant rearing on
immune development, and knowing that there is a dif-
ferential median age of seroconversion to RhCMV, SFV,
and RRV during the first year of life in outdoor-housed
rhesus macaques, we evaluated the effect of chronic
pathogen exposure on host immunity by comparing ado-
lescent SPF-2 and non-SPF macaques. Both of these
animal cohorts were housed outdoor under identicalFigure 7 Viral and immune parameters of RhCMV infection. Panel A show
n = 50) or adult (filled diamonds; n = 100) non-SPF macaques. Each symb
median of the age group. In Panel B, neutralizing plasma antibody titers
The legend is similar to Panel A. Neutralizing antibodies were correlated
(Panel D) macaques. Statistically significant differences are indicated by pconditions and therefore exposed to identical microbes
in the environment; thus, the major apparent distinction
between SPF-2 and non-SPF adolescent macaques was
their infection with RhCMV, SFV and RRV. In addition,
we established whether pathogen-induced immune
modulation in adolescent non-SPF macaques persisted
into adulthood or whether aging resulted in additional
immunological changes.
Our cross-sectional analysis of infant, adolescent and
adult macaques suggests that both SPF-2 and non-SPF
macaques experience a significant decrease in lympho-
cyte numbers with aging. Concurrently, the composition
of the T and B cell populations changed. With increasing
age, and presumably pathogen exposure, effector and
memory T and B cells developed and T cell maturation
was associated with functionally improved T cell re-
sponses. These age-related immunological changes weres the quantity of RhCMV shed orally by adolescent (filled triangles;
ol represents an individual animal; horizontal lines indicate the
for RhCMV-infected adolescent and adult macaques are shown.
with oral RhCMV shedding in adolescent (Panel C) or adult
values.
Figure 8 Cytokine responses to in vitro RhCMV stimulation. Each graphs represents the amount (pg/ mL) of a specific cytokine produced in
response to RhCMV lysate after 48 hours of stimulation. Each symbol is representative of a single animal and horizontal bars indicate median
cytokine levels for each age group. A total of 10 adolescent and 10 adult non-SPF macaques were included in the analysis. Statistically significant
differences are indicated by p values.
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ences in the quality and magnitude of these changes
suggested that chronic pathogen exposure could modu-
late host immune responses. Specifically, memory T
cells, in particular CD4+ memory T cells, occurred at
higher levels in non-SPF than in SPF-2 adolescent and
adult macaques. Similarly, adolescent and adult non-SPF
animals had higher frequencies of isotype-switched
memory B cells than SPF-2 macaques of the same age.
These differences in specific lymphocyte subsets likely
contributed to the observed distinct cytokine responses
after mitogenic T cell stimulation. Non-SPF adolescent
macaques produced higher levels of cytokines, in par-
ticular proinflammatory cytokines, compared to their
age-matched SPF-2 adolescent macaques. It is plausible
that the active replication of RhCMV in adolescent ma-
caques, that was reflected in their more frequent shed-
ding patterns of RhCMV in oral fluids, contributed to
the more inflammatory cytokine profile of non-SPF com-
pared to SPF-2 adolescent macaques. Moreover, these
qualitatively distinct responses in adolescent macaques
were indicative of early predisposition of adolescentRhCMV-infected animals to “inflammaging” in adult
macaques, and supported our hypothesis that chronic
RhCMV infection could broadly modulate host immune
responses.
To corroborate this conclusion further and to assess
the biological relevance of these findings, we evaluated
how RhCMV infection status and associated virologic
and immunologic markers related to the age-related
changes specific for non-SPF macaques. More than 90%
of conventionally housed rhesus macaques are infected
with RhCMV by 1 year of age [38-40], and, similar to
humans, RhCMV persists in rhesus macaques through-
out their lifespan [31,38,40,46,47]. Indeed, all of the ado-
lescent and adult non-SPF macaques in the current
study tested seropositive for RhCMV. Interestingly, ado-
lescent and adult non-SPF macaques had comparable
titers of RhCMV-specific neutralizing plasma antibody
titers, suggesting that, once elicited, neutralizing anti-
bodies to RhCMV persist at relatively constant levels.
Further, we concluded that the magnitude of the neu-
tralizing antibody response was not dependent on anti-
genic load because we observed significantly higher and
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adult RhCMV-infected macaques. Although, our studies
were not designed to determine a causal relationship, we
would speculate that the induction and development of
RhCMV-specific antibodies in adolescent non-SPF ma-
caques was a contributing factor in the development of
more mature B cells in non-SPF compared to SPF-2 ma-
caques. Memory T cell expansion is a well-described
phenomenon in human HCMV infection and in RhCMV
infection in rhesus macaques [31,48,49]. While we did
not measure actual frequencies of RhCMV-specific
memory T cells, we noted significantly higher effector
CD4+T cell and increased CD28-negative CD8+T cell
populations in non-SPF compared to SPF macaques.
Consistent with memory T cell inflation, adult compared
to juvenile non-SPF macaques produced higher cytokine
levels in response to RhCMV stimulation.
To conclusively define the underlying mechanisms
leading to inflammaging, future longitudinal and com-
parative studies between animals of SPF-2 and non-SPF
colonies are needed. Such studies could address (i) how
normal aging or immunosenescence differ from inflam-
maging, (ii) which processes regulate and control inflam-
maging, (iii) whether genetic factors contribute to
inflammaging in chronically infected humans, (iv)
whether RhCMV or other chronic infections induce epi-
genetic changes in immune cell populations, and (v)
whether pathogen-induced immune modulation would
be reversible if recognized earlier in life.
Conclusions
The results of our study validate rhesus macaques as a
relevant animal model to study how chronic viral infec-
tions modulate host immunity and impact immunose-
nescence. Immunological aging is reflected in similar
phenotypic and functional changes of peripheral blood
cell population in in SPF-2 and non-SPF macaques from
birth throughout adulthood. The changes in the immune
repertoire of SPF-2 and non-SPF macaques that were
associated with aging and infectious burden of persistent
viruses recapitulate changes in lymphoid subsets observed
in aging and HCMV-infected humans.
The identification of noticeable differences between ado-
lescent SPF-2 and non-SPF macaques suggests that
chronic infections, in particular RhCMV infection, modu-
late host immune development and aging. The changes in
lymphoid subsets are hallmarks of two non-mutually ex-
clusive interpretations of virus-host interactions. (1) As
the viruses that define SPF-2 status establish lifelong per-
sistent infections, the observed changes between age-
matched SPF-2 and non-SPF animals must be considered
as a phenotype of viral persistence in an immune-
competent host. (2) Both primary and persistent infections
of all of the SPF-2 viruses are subclinical. Therefore, thedistinctions in the lymphoid repertoire must be considered
as a phenotype of protective immune responses.
The distinctions in the relative skewing towards Th2
versus Th1-type of responses in SPF-2 and non-SPF ani-
mals, respectively, are consistent with a viral type of
adjuvant effect that enables the seeming conundrum in
which the SPF-2 pathogens stimulate antiviral immune
responses in immune competent hosts that protect
against viral sequelae, yet fail to clear reservoirs of per-
sistent virus.
Comparative studies in SPF-2 and non-SPF macaques
could identify important mechanisms associated with
inflammaging and thereby lead to new therapies promot-
ing healthy aging in humans.
Methods
Animals
The rhesus macaques (Macaca mulatta) used in this
study were part of the California National Primate Re-
search Center (CNPRC) breeding colony on the Univer-
sity of California, Davis campus. The Institutional
Animal Care and Use Committee of the University of
California, Davis (UC Davis), which is fully accredited by
the Association for Assessment and Accreditation of La-
boratory Animal Care, approved all animal protocols in
advance of any procedures. Rhesus macaques generally
reach puberty around four years of age. For this study,
cohorts of animals 3 to 5 years of age (adolescent to
young adult) were evaluated and are referred in the text
as adolescent macaques. Rhesus macaques can live up to
30 years at the CNPRC, and aged macaques are defined
as ≥14 years of age.
Genetically outbred infant rhesus macaques (Macaca
mulatta) of Indian (n = 13; 8 male and 5 female infants)
or Chinese (n = 10; 8 female and 2 male infants) origin
were obtained from the Specific Pathogen-Free Level 2
(SPF-2) colony at the California National Primate Center
(CNPRC). SPF-2 status was defined as being seronega-
tive for the SPF Level 1 viruses simian type D retrovirus
(SRV), simian immunodeficiency virus (SIV), simian T
cell lymphotropic/leukemia virus (STLV), and Cerco-
pithecine herpesvirus 1 (CHV-1; herpes B virus), and in
addition being uninfected with RhCMV, simian foamy
virus (SFV), and rhesus rhadinovirus (RRV) [50]. SPF-2
infant macaques were reared indoors in the SPF-2
nursery. At the age of 9 months to 1 year, they were
relocated to outdoor SPF-2 animal corrals and were
not co-housed with non-SPF animals. SPF-2 adoles-
cent macaques (n = 20; 3 to 4 years), and non-SPF
adolescent (n = 50; 3 to 5 years) or adult non-SPF
macaques (n = 100; 12 to 20 years) were of Indian
origin and housed outdoors in half-acre corrals. In
addition, a smaller cohort of 8 young adult SPF-2
macaques (6 to 10 years) was included, the maximum
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the time of the study. Representative of the CNPRC
colony’s effort to increase breeding age of female
macaques, the gender distribution was shifted toward
female macaques that represented 65% of SPF-2
adolescent, 42% of non-SPF adolescent, and 70.5% of
adult non-SPF macaques.Sample collection and processing
Animals were immobilized with (10 mg/kg) ketamine-
HCl intramuscularly (IM) prior to all sample collections.
Complete blood counts (CBC) were performed at each
blood collection. Infant EDTA blood samples were col-
lected longitudinally starting at birth and subsequently
every month for one year. Plasma was removed from
whole blood by centrifugation and stored at −80°C for
antibody measurement. Peripheral blood mononuclear
cells (PBMC) were isolated from whole blood via density
centrifugation using Lymphocyte Separation Medium
(LSM) (MP Biomedicals, Solon, OH) or Accu-Paque
Lymphocyte separation media (Accurate Chemical &
Scientific Corp., Westbury, NY) as described [51-53].
Due to the low blood volume that could be collected
from infant macaques, and therefore relatively low cell
counts, infant PBMC were used immediately for func-
tional analyses. PBMC from adolescent and adult ma-
caques were cryopreserved for functional assays and
batch-analysis.Complete blood count (CBC)
EDTA blood samples were analyzed on a HORIBA Pen-
tra 60+ electronic cell counter (HORIBA Diagnostics,
Irvine, CA). A standard blood smear was prepared from
the EDTA sample and stained with a Wright-Giemsa
stain (Harleco, EM Scientific, Gibbstown, NJ). Manual
100-cell differentials were performed for the differenti-
ation of white blood cells. The relative percentage of
each cell type was obtained and then multiplied by the
total white blood cell count to get the absolute numbers
of each cell population.T cell receptor (TCR) stimulation of SPF-2 macaques
Microtiter tissue culture plates were coated overnight
with 5 μg/ml of pure anti-CD3 (clone SP34-2) and 5 μg/
ml pure CD28 (clone L293) in 100 μl of PBS/ well. The
next day, plates were washed 3× with PBS. PBMC
(1×106 cells/ ml) were then plated at 100 μl/ well and
cultured for 24 hours at 37°C and 5% CO2. Supernatants
were collected and stored at −80°C until analysis using
the Milliplex MAP Nonhuman Primate Cytokine Panel
(EMD Millipore, Billerica, MA).Concanavalin A (ConA) and RhCMV antigen stimulation
PBMC (1.25 × 106 /ml) from adolescent and adult ma-
caques were resuspended in RPMI/10% FBS and stimu-
lated with 25 μg/ml concanavalin A (Con A) or 25 μg/
ml RhCMV lysate prepared from an infected cell extract
exhibiting 100% cytopathic effect. Negative control
cultures consisted of cells in media only. Cell culture
supernatants were collected after 48 hours and were
immediately analyzed in duplicates for multiple sol-
uble markers using multiplex bead arrays (Bioplex
Suspension Array System with Bioplex Manager 4.0
software by Bio-Rad Laboratories, Hercules, CA, or
Milliplex MAP Nonhuman Primate Cytokine Panel by
EMD Millipore).Flow cytometric analysis
Infant PBMC T cell or B cell populations were analyzed
for activation or memory cell differentiation using stand-
ard surface staining protocols [51-53]. The ability of the
CD4+ and CD8+ T cells to produce cytokines in response
to PMA/ionomycin stimulation was evaluated using the
following logical gating strategy: PBMC gate (FSC-A vs.
SSC-A), singlets (FSC-H vs. FSC-A), T cells (CD3+CD4+
or CD3+CD8+), followed by gating for IFN-γ, IL-2 and/
or TNF-α within the CD4+ or CD8+T cell populations. T
cell activation and maturation were determined by in-
cluding Ki67, HLA-DR, CD38, CCR5, CXCR3, CD45RA,
CD28, and/or CD95 in the analysis. Samples were ac-
quired on a FACS Aria flow cytometer (BD Biosciences,
San Jose, CA).
In addition, infant PBMC were resuspended with
RPMI 1640 media (Cellgro, Manassas, VA) supple-
mented with 10% heat-inactivated FBS (Cellgro,
Manassas, VA) and L-glutamine-penicillin-strepto-
mycin antibiotic cocktail (Sigma, St Louis MO) at 1.0
×106 cells/ml. Negative controls were cultured in media
only. To evaluate polyclonal T cell responses, PBMC
were stimulated with phorbol myristate acetate (PMA)
at 10 ng/ml and ionomycin at 125 ng/ml (Sigma). The
cells were incubated for a total of 12 hours at 37°C and
5% CO2 with Brefeldin A (3.0 μg/ml) being added after
the first hour (eBioscience, San Diego, CA). At the end
of the culture period, cells were stained for surface
antibodies, fixed, and permeabilized for intracellular
cytokine staining (see below) and as described previ-
ously [51-53]. A minimum of 300,000 events were ac-
quired for T cell stimulation responses and 30,000
events for phenotyping studies. Data were analyzed
using FlowJo Software (Tree Star, Ashland, Oregon)
and Boolean gating strategies were applied when appro-
priate. Cytokine responses in CD4+ or CD8+ T cells
were considered positive if their frequencies were at
least 2 times higher than in unstimulated (media)
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reported as percentage of CD4+ or CD8+ T cells.
To analyze T cell maturation and activation in adoles-
cent and adult macaques, whole blood samples were
stained by direct labeling with the relevant antibody
cocktails and processed using the Coulter TQ Prep
System (Coulter Corporation, Hialeah, FL) to lyse red
cells and fix the stained PBMC. Samples were acquired
on a FACS Calibur and analyzed with CellQuest soft-
ware (BD Biosciences, San Jose, CA).
RhCMV antibody measurement
RhCMV neutralizing antibodies (nAb) were determined
as described previously [51,52]. Data are reported as the
reciprocal of the dilution that resulted in 50%
neutralization (NT50).
RhCMV quantitation
Oral saliva swabs were collected from both RhCMV-
seropositive non-SPF adolescents and adults. RhCMV
was quantitated as previously described [54,55]. Real-
time PCR for RhCMV gB was performed using the
following primer and probe pair: forward primer: 5′-T
GC GTA CTA TGG AAG AGA CAA TGC-3′, reverse
primer: 5′-ACA TCT GGC CGT TCA AAA AAA C-3′
(Invitrogen, Carlsbad, CA), and probe (5′-3′) TET-CCA
GAA GTT GCG CAT CCG CTT GT-TAMRA (Applied
Biosystems, Carlsbad, CA). RhCMV was quantitated based
on a RhCMV gB plasmid standard curve spanning 10° to
106 copies; the limit of detection being 10 copies. The viral
load was calculated as RhCMV gB copies per ml for saliva.
Statistical analysis
The data are presented as median values if not indicated
otherwise. The Wilcoxon signed ranked test was applied
to determine whether changes in absolute cell numbers
or percentages of cell populations between birth and
1 year of age reached statistical significance. Results be-
tween two or more independent groups were compared
by Student’s t-test or one-way ANOVA, respectively,
using GraphPad Prism, version 5 (GraphPad, Inc., La
Jolla, CA). Nonparametric Mann–Whitney tests or
Kruskal-Wallis tests with Dunn’s multiple comparison
adjustments were applied when we observed large vari-
ation within a group, which is not untypical due to the
outbred nature of rhesus macaques. To test whether
there was an age-dependent increase in IFN-γ producing
CD4+ and CD8+T cells from birth to 1 year of age, not
necessarily on an individual basis, but on a population
basis, an exact statistical test was applied. For each animal
and cytokine outcome, an early (week 0–4) and late (week
40–48) measurement was derived from the arithmetic
mean of three scheduled measurements during the re-
spective timeframes. These timeframes were chosen priorto conducting statistical analysis. An exact Wilcoxon
signed-rank test was used to test the null hypothesis that
the late - early differences have a median of 0. A Hodges-
Lehmann estimate of location shift and corresponding
95% confidence interval were also computed using R ver-
sion 2.15.1 (http://www.r-project.org). Statistical inference
was performed for IFN-γ in CD4+ and CD8+T cells with-
out adjustments for multiple testing.
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